Badawi Paul 4

What Happened Paul Badawi, reported as a 10% owner of Sight Sciences, received a grant of 154,560 restricted stock units (RSUs) on February 3, 2026. The award was reported at an acquisition price of $0.00 and is equal to $1,000,000 divided by the closing stock price on the grant date (total value cited as $1.0M). Each RSU represents a contingent right to one share of common stock upon vesting.

Key Details

• Transaction date: 2026-02-03; Form 4 filed 2026-02-05 (timely).
• Transaction type/code: Award/Grant (A); 154,560 RSUs granted at $0.00.
• Vesting: 16 equal quarterly installments beginning March 31, 2026 through December 31, 2029, subject to continued service.
• Reported holdings (per filing): 5,517,778 shares of common stock and 662,622 shares that will be acquired upon vesting of unvested RSUs (per footnote).
• No sale or open-market purchase occurred—this is a compensation award, not a market buy.

Context RSUs are a form of equity compensation that convert to actual shares only as they vest; they do not represent immediately tradable shares. Such grants are common for compensation and retention and do not, by themselves, indicate an insider buying or selling for market exposure. As a 10% owner, Badawi’s transactions are reported under insider ownership rules rather than routine open-market trading.